AntoniusArthurMillerMD

Oncology • Winston Salem, NC

Hematologic Oncology, Thoracic Cancer

Professor of Medicine, Wake Forest University

Join to view full profile

Dr. Miller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Miller's full profile

Already have an account?

Office
Medical Center Blvd
Winston Salem, NC 27157
Phone+1 336-716-2255
Is this information wrong?

Education & Training

University of TennesseeResidency, Internal Medicine, 1986 - 1987
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1980 - 1981
Heinrich Heine University of DusseldorfClass of 1977

Certifications & Licensure

NC State Medical License 2000 - 2021

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2010-2014
America's Top Doctors for Cancer Castle Connolly, 2009-2013
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

Paclitaxel in Treating Women With Recurrent Solid Tumors Start of enrollment: 1997 Nov 01
Completed
Phase 2
Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer Start of enrollment: 2001 Apr 01
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2001 Nov 01
Completed
Phase 2
Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2001 Nov 01
Completed
Phase 2
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Start of enrollment: 2001 Dec 01
Completed
Phase 1
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Start of enrollment: 2001 Sep 01
Completed
Phase 2
Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression Start of enrollment: 2004 Mar 01
Completed
Phase 3
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2004 Aug 01
Completed
Phase 2
Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function Start of enrollment: 2004 Oct 01
Completed
Phase 1
Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2000 Nov 01
Completed
Phase 2
Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Start of enrollment: 2003 Nov 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

43 citations
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of Light.
Fausto Acernese, M. Agathos, Lloyd Paul Aiello, A. Allocca, Anthony A. Amato, Stefano Ansoldi, S. Antier, M. Arène, N. Arnaud, S. Ascenzi, P. Astone, F. Aubin, Stanisl...> ;Physical Review Letters. 2019 Dec 6
11 citations
Tests of General Relativity with GW170817
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;Physical Review Letters. 2019 Jul 3
44 citations
Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.
Jimmy Ruiz, Antonius A. Miller, Janet A. Tooze, Sandrine Crane, William J. Petty, Ajeet Gajra, Heidi D. Klepin> ;Journal of Geriatric Oncology. 2019 Jan 1
iPTF16geu: A Multiply Imaged, Gravitationally Lensed Type Ia Supernova
Y Cao, M Kasliwal, A A Miller, D Wilson> ;Science Magazine. 2017 Apr 22
23 citations
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma.
Paul D. Savage, James Lovato, K. Bridget Brosnihan, Antonius A. Miller, W. Jeffrey Petty> ;Sarcoma. 2016 Nov 8
40 citations
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.
Thomas Lycan, Timothy S. Pardee, William J. Petty, Marcelo Bonomi, Angela Tatiana Alistar, Zanetta S. Lamar, Scott Isom, Michael D. Chan, Antonius A. Miller, Jimmy Ruiz> ;Plos One. 2016 Oct 12
19 citations
Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients.
J.M. Kilburn, Michael H. Soike, John T. Lucas, D.N. Ayala-Peacock, William Blackstock, Scott Isom, W.T. Kearns, William H. Hinson, Antonius A. Miller, William J. Petty...> ;Practical Radiation Oncology. 2016 May 1
10 citations
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling.
CH Li, Robert R. Bies, Yaning Wang, Sharma, Sanja Karovic, L Werk, Martin J. Edelman, Antonius A. Miller, Everett E. Vokes, Aytekin Oto, Mark J. Ratain, Lawrence H. Sc...> ;Clinical and Translational Science. 2016 Feb 1
106 citations
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—...
Neal Ready, Herbert Pang, Lin Gu, Gregory A. Otterson, Sachdev P. Thomas, Antonius A. Miller, Maria Q. Baggstrom, Gregory A. Masters, Stephen L. Graziano, Jeffrey Craw...> ;Journal of Clinical Oncology. 2015 May 20
116 citations
Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center
Jennifer A. Lewis, W. Jeffrey Petty, Janet A. Tooze, David P. Miller, Caroline Chiles, Antonius A. Miller, Christina Bellinger, Kathryn E. Weaver> ;Cancer Epidemiology, Biomarkers & Prevention. 2015 Jan 22
7 citations
Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance)
Xiaofeng Wang, Kouros Owzar, Pankaj Gupta, Richard A. Larson, Flora Mulkey, Antonius A. Miller, Lionel D. Lewis, David D. Hurd, Ravi Vij, Mark J. Ratain, Daryl J. Murry> ;British Journal of Clinical Pharmacology. 2014 Nov 1
24 citations
Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung c...
S.C. Lester, John T. Lucas, Michael H. Soike, A. William Blackstock, W.T. Kearns, William H. Hinson, Antonius A. Miller, William J. Petty, Michael T. Munley, James J. ...> ;Journal of Thoracic Oncology. 2014 Apr 1
58 citations
Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment.
J.M. Kilburn, J.G. Kuremsky, A. William Blackstock, Michael T. Munley, W.T. Kearns, William H. Hinson, James Lovato, Antonius A. Miller, William J. Petty, James J. Urb...> ;Radiotherapy and Oncology. 2014 Mar 1
3 citations
Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer.
W. Jeffrey Petty, Jennifer Laudadio, James Lovato, Travis Dotson, Nathan P. Streer, Kathryn E. Weaver, Antonius A. Miller> ;International Journal of Oncology. 2013 Dec 1
22 citations
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance)
Lionel D. Lewis, Antonius A. Miller, Kouros Owzar, Robert R. Bies, Svetlana Markova, Chen Jiang, Deanna L. Kroetz, Merrill J. Egorin, Howard L. McLeod, Mark J. Ratain> ;Pharmacogenetics and Genomics. 2013 Jan 1
10 citations
Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1α in vascular sarcomas.
W. Jeffrey Petty, Mebea Aklilu, Victor A. Varela, James Lovato, Paul D. Savage, Antonius A. Miller> ;BMC Cancer. 2012 Sep 11
Phase II study of dose-dense chemotherapy followed by dose-intense erlotinib for initial treatment of metastatic NSCLC.
Waller LL, Miller AA, Streer NP, Lovato JF, Petty WJ> ;J. Clin. Oncol.. 2011-05-20
24 citations
Effects of continued tobacco use during treatment of lung cancer.
Kathryn E. Weaver, W. Jeffrey Petty, Antonius A. Miller> ;Expert Review of Anticancer Therapy. 2010 Oct 1
38 citations
A Phase II Study of Dasatinib in Patients with Chemosensitive Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30602)
Antonius A. Miller, Herbert Pang, Lydia Hodgson, Nithya Ramnath, Gregory A. Otterson, Michael J. Kelley, Robert A. Kratzke, Everett E. Vokes> ;Journal of Thoracic Oncology. 2010 Mar 1
19 citations
Differences in Clinical Trial Patient Attributes and Outcomes According to Enrollment Setting
Elizabeth B. Lamont, Mary Beth Landrum, Nancy L. Keating, Laura Archer, Lan Lan, Gary M. Strauss, Rogerio Lilenbaum, Harvey B. Niell, L. Herbert Maurer, Michael P. Kos...> ;Journal of Clinical Oncology. 2010 Jan 10
14 citations
Using erlotinib to treat patients with non-small cell lung cancer who continue to smoke
Antonius A. Miller, W. Jeffrey Petty> ;Lung Cancer. 2010 Jan 1
34 citations
A phase I study of gefitinib with concurrent dose-escalated weekly docetaxel and conformal three-dimensional thoracic radiation followed by consolidative docetaxel and...
William J. Petty, Diandra N Ayala, William H. Hinson, James Lovato, James Capellari, Timothy E. Oaks, Antonius A. Miller, Arthur W. Blackstock> ;Journal of Thoracic Oncology. 2010 Jan 1
73 citations
Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone
W. Jeffrey Petty, Antonius A. Miller, Thomas P. McCoy, Patricia E. Gallagher, E. Ann Tallant, Frank M. Torti> ;Clinical Cancer Research. 2009 Dec 1
59 citations
Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database
Brian E. Lally, Ann M. Geiger, James J. Urbanic, Jerome M. Butler, Stacy Wentworth, Michael C. Perry, Lynn D. Wilson, Janet K. Horton, Frank C. Detterbeck, Antonius A....> ;Lung Cancer. 2009 May 1
165 citations
Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301
, , , , , , , , , , , , , , , > ;Journal of Clinical Oncology. 2009 Apr 10
Join now to see all